JFIFdPhotoshop 3.08BIMH@HKUMed Pioneers Innovative Combination Therapy to Lower Leukemia720260612PSCIENMAGUAuthorxHKUMed Pioneers Innovative Combination Therapy to Lower Leukemia Relapse and Extend Bone Marrow Transplant Opportunities Science@https://scienmag.com/hkumed-pioneers-innovative-combination-ther© 2026 Sciencehttps://scienmag.com/A groundbreaking therapeutic strategy has emerged from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong (HKUMed), promising to reshape the treatment landscape for acute myeloid leukemia (AML) patients harboring FLT3 gene mutations. This novel combination therapy, designated QUIZOM, pairs the potent FLT3 inhibitor Quizartinib with […]ScienceCanCancerCancer0bone marrow transplant opportunities in leukemia/enhancing immune response in leukemia treatment/extending survival in FLT3-mutated AML patients(FLT3 internal tandem duplication therapy FLT3 mutation targeted treatment*improving remission rates in high-risk AML9innovative combination therapy for acute myeloid leukemia)novel therapies for hematologic neoplasms#protein synthesis inhibitors in AML#Quizartinib and Omacetaxine synergy QUIZOM therapy clinical outcomesreducing AML relapse ratesC    !'"#%%%),($+!$%$C   $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$"9!1A"Qaq2B#R3r$%45!1AQ#a"23q$4BR ?hzwv님u\u VF7ׯqg7Q$ q4$&3kF2wV)$~fr$OaU{ hW$zRkX#s:dKŒu8FE67+WK1ŸafuWDySZJhntpyP=wNLq=.i3=;G][}+0U/]cѮ7ǀ>j`YT~RycRq\Nޞ}~陃#>J,+I /?;Y"AEM3^jL"ޣpE.srEur$jKs50ǂT4AkE{-2H޳5ܔCh?[\2$Is;UG0(HZmF=`ڬߗXRCrstW7 b4X[iQ6V*wRrJ Q@)m VRYbpE]n4nG;a\Gj[͜$ -=S^ࠪ2 {t}áiZ\I hJcEEÃqkPOR֋ #D. :~jʕWP`X/AuaÑ胺 pp(|+oÎވ֏fF;kSy>%xQTĘ|&j!Ts,߇?^4VT.VE3Z,q~}GikD tyQy5X٣ؿa#:9Cn*Rm;\t%y0ڬ|;> `qpl'E*d}a 4,#ǐzQ /w"Nc0cv((-÷'rrc|!emҪɪ73HVĞ>{;-UVB}&$S]J̈́fu v=i S{~X89P9_AkRݦmM F ~*dzGi!M`Pkinci#BʽqR[Kmm89)mxeN{HJTv@;Kg&>_: !ŸNMFL%-MҰ¡9N@䬊Lyl=-@BI!\7էpGJQeTx/avEF4R&WK0ndD-tli V1$,bXwOq+n-NmԚ:VvF+t eR9OtZAvE/2 MFeB\NJXZk[y)Cox(KKnǐtp7R+&0c5܇EG7 #I2ZՑdQ)h{| rҥ:x[xIT3ՆkUmu=AM2 2矱_n%RgĝNNOktCHK7pFD'ܫ9Vo0n!Wm+c/zQŜN7<{զQ@sݕX 39vFU;Vq'xC2julJw}=ĩDsU('lR^sJ,^h>r,Ps]GHTOjlۂ$g a_ Rkd[r@d݈}A7:[FP#p붳X2 RUd#~xglZFiEC.V qङÁ]~Rt27j[rEXtC]Cc~KN#nyU˒'hF&?B+q(dsHׅ*21˧jڌ%tV9lʒ`G`{RԵJvI;I&Da9)?COXxC\jZ/s:A#ڂs5eu֖#mHmbsV}?4Lsrj~X3c㠪׉wmFIf_1h 4lw/5ݛMsUM6aK2`f^:[Lt==f07׵|zNO̾\t55sR ɅogKC.fd yu ^>D1膶Xp#ip9WJj:ܲM C*#ZTid;QmZyrf CH}nb4#MX<(}mX$Ȇxb?>ީXz)p:A o Bp߱4-WO?G4 9XA>@>2*b胇$t5ʓpcgک$:\. xw4)D٪[{ys Lu 찇յInc^b$Yeͪ>@tQUR.، UخcaLEڗudVF5k+_A֢)e ېU!+)$k #?ov[}=ecڡ7cnuION[ԅ5ϼ=)V|4I('GC AU_u],`(7^4RM$qQ; èRxlфd;QuuPKDp#n|8N ["Um:hE?*r@kSE}hKjCW ߙ+ m;U#oyW+*(AB38-.+t] Km(NɸҬ҂_JCz`&:C^JX;NkUk wc^E룆p`f(H\ Sm(ߊ,GeS͛Kuk~i\EffubPR29=ɩ kw~͵ iN`6-(/Ħc M("rTXaFqkz328&m]CYQظhosJ4O@@%AdIPVPݚB4q$s)|{?Iy5i:E`̌KRn5*rr()SޛQYA^;c:H{"yMdK)#8j<24/ܑ8ž$yWNz2{)R0}1yQ]_?%!o,jzyy(v>D9O3MJFCljEu\ISCs6ڙv]6ŻJ})@?洹&I{kV;d9Z򵿙րqjrڗa| )^%>kڡirK61;MQQDvbTsiKڕFܱUZ@W`W^|%WiQm:(FA`˟֩bq\cUO,-dݷcڇ'Cfib;%J)<&$~ P KX1s΅Ms,H64]($hI )sȱ1+S (J0+(M2!tBY,xy T1Z Vms4´{R DܱVyvqYCi=27kLҤi>(3<Ď"6<Pm|}e0GuVfiJ60 !u,Lc _z?e 9R !S5UUzzR^jI ebupʩ8RBW]QJz~p͞~JsZCҤ*T俆J*mnS4R,Eo}R{L. ??J~қ`V<6 kX?.vT\ ˹JUk